CVR Medical Past Earnings Performance

Past criteria checks 0/6

CVR Medical has been growing earnings at an average annual rate of 34.1%, while the Medical Equipment industry saw earnings growing at 9.1% annually.

Key information

34.1%

Earnings growth rate

48.3%

EPS growth rate

Medical Equipment Industry Growth-19.2%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Mar 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How CVR Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:CVM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 220-200
31 Dec 210-210
30 Sep 210000
30 Jun 210000
31 Mar 210000
31 Dec 200000
30 Sep 200-211
30 Jun 200-211
31 Mar 200-322
31 Dec 190-532
30 Sep 190-753
30 Jun 190-862
31 Mar 190-852
31 Dec 180-742
30 Sep 180-631
30 Jun 180-631
31 Mar 180-521
31 Dec 170-731
30 Sep 170-722
30 Jun 170-622
31 Mar 170-521
31 Dec 160-211
30 Sep 160-110
30 Jun 160000
31 Mar 160000
31 Dec 150000

Quality Earnings: CVM is currently unprofitable.

Growing Profit Margin: CVM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CVM is unprofitable, but has reduced losses over the past 5 years at a rate of 34.1% per year.

Accelerating Growth: Unable to compare CVM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CVM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).


Return on Equity

High ROE: CVM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.